Johnson & Johnson shares are trading lower after the company reported Q3 financial results and raised its FY26 sales guidance with its midpoint below estimates.
Johnson & Johnson shares are trading lower after the company reported Q3 financial results and raised its FY26 sales guidance with its midpoint below estimates.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed